Search

Your search keyword '"Kanako Shimizu"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Kanako Shimizu" Remove constraint Author: "Kanako Shimizu" Topic biology Remove constraint Topic: biology
46 results on '"Kanako Shimizu"'

Search Results

1. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2

2. Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer

3. Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity

4. Eomes transcription factor is required for the development and differentiation of invariant NKT cells

5. Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo

6. Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells

7. Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN

8. Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses

9. Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells

10. Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice

11. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanismviarecruitment of myeloid-derived suppressor cells

12. Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells

13. In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus

14. Prolonged Antitumor NK Cell Reactivity Elicited by CXCL10-Expressing Dendritic Cells Licensed by CD40L+CD4+ Memory T Cells

15. Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Vα14-Jα18 TCRα gene

16. Dendritic cell-based cancer immunotherapies

17. Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity

18. DC therapy induces long-term NK reactivity to tumors via host DC

19. Innate Vα14+natural killer T cells mature dendritic cells, leading to strong adaptive immunity

20. Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells

21. Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using α-Galactosylceramide-Loaded Murine Dendritic Cells

22. Maturity discrimination of snake fruit(Salacca edulis Reinw.) cv.Pondoh based on volatiles analysis using an electronic nose device equipped with a sensor array andfingerprint mass spectrometry

23. Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes

24. Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein

25. A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma

26. Detection and activation of human Vα24+ natural killer T cells using α-galactosyl ceramide-pulsed dendritic cells

27. Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential

28. KLRG+ invariant natural killer T cells are long-lived effectors

29. Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

30. Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses

31. NKT cells as an ideal anti-tumor immunotherapeutic

32. Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction

33. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells

34. ChemInform Abstract: An Artificial Substrate for the Thermostable Farnesyl Diphosphate Synthase from Bacillus stearothermophilus

35. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells

36. Human leukemic cells loaded with alpha-galactosylceramide (alpha-GalCer) activate murine NKT cells in situ

37. An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunity

38. Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice

39. Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma

40. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

41. Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ

42. Hematopoietic stem cells (+iPS) (WS-010)

43. Is prophylactic haptoglobin infusion in peripheral blood stem cell transplantation clinically useful?

44. Generation of Melanoma Antigen Specific T Cells From Human Ips Cells Using a Feeder Free System

45. P84. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells

46. An Artificial Substrate for the Thermostable Farnesyl Diphosphate Synthase fromBacillus stearothermophilus

Catalog

Books, media, physical & digital resources